Invention Grant
- Patent Title: Inhibitors of IGFBP3 binding to TMEM219 for treatment of intestinal diseases
-
Application No.: US15579573Application Date: 2016-06-06
-
Publication No.: US10682391B2Publication Date: 2020-06-16
- Inventor: Francesca D'Addio , Paolo Fiorina
- Applicant: OSPEDALE SAN RAFFAELE SRL
- Applicant Address: IT Milan
- Assignee: Ospedale San Raffaele SRL
- Current Assignee: Ospedale San Raffaele SRL
- Current Assignee Address: IT Milan
- Agency: Fenwick & West LLP
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@323cebde
- International Application: PCT/EP2016/062790 WO 20160606
- International Announcement: WO2016/193496 WO 20161208
- Main IPC: A61K38/17
- IPC: A61K38/17 ; C07K16/18 ; A61K45/06 ; G01N33/68
Abstract:
The present invention relates to an inhibitor of IGFBP3 binding to TMEM219 and uses thereof for the treatment and/or prevention of an intestinal disease in a subject, in particular the treatment and/or prevention of diabetic enteropathy or inflammatory bowel disease.
Public/Granted literature
- US20180172708A1 IGFBP3 AND USES THEREOF Public/Granted day:2018-06-21
Information query
IPC分类:
